GROV Q1 2026 Earnings Significant EPS Beat Amid Cost Discipline ALZN Q1 2026 Earnings EPS Surprise of 7046 as Loss Narrows Sharply from Analyst Expectations UBFO Q4 2025 Earnings Modest Earnings in a Quiet Quarter Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues RIVN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Nexxen International Q3 2025 Earnings Strong EPS Surprise Amplifies Confidence in Profitability